Study 17 of 33Erythropoietin (EPO) literatureNature medicineTop journal2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.
Not reported in abstract.
Where it sits
this study against the rest of the erythropoietin (epo) corpus5
Preclinical · this one
21
Observational
1
Open-label
2
Randomised
4
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the Erythropoietin (EPO) corpus
DPrevalence and risk of cardiovascular events among people living with HIV: a meta-analysis.Annals of medicine · 2026 · Pooled prevalence of cardiovascular events was 6% (95% CI: 0.05-0.07).reviewBReal-world effectiveness of central dialysis fluid delivery system (CDDS) in maintenance hemodialysis: a retrospective multicenter study.Renal failure · 2026 · β = 3.50 g/L hemoglobin compared to SPDDS, p < 0.05HumanBImpaired fasting glucose is comparable to diabetes mellitus in predicting mortality and cardiovascular events in patients undergoing peritoneal dialysis: the role of β-cell function and insulin resistance.Renal failure · 2026 · n=216 · IFG independently predicted all-cause mortality (HR, 2.48; 95% CI, 1.16-5.32; p=0.02).HumanBThe relationship between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and tubular atrophy/interstitial fibrosis in patients with IgA nephropathy.Renal failure · 2026 · n=400 · NHHR was positively correlated with T lesions (r = 0.229, p < 0.001).HumanBAssociation Between Perioperative Daprodustat Use and Early Posttransplant Graft Function in Living Donor Kidney Transplantation: A Propensity Score-Matched Retrospective Study.Current therapeutic research, clinical and experimental · 2026 · n=64 · Week 1 estimated glomerular filtration rate: 53.3 ± 16.1 vs control 41.9 ± 17.9 mL/min/1.73 m²; P = 0.001HumanCAnalytical validation of an ultrasensitive multiplexed immunoassay for blood-based biomarkers GFAP, NF-L and taubiorxiv-preprint · 2026 · Intra-plate %CV averaged less than 10%.In vitro